WINDTREE THERAPEUTICS INC /DE/ Severance Costs
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Severance Costs of $200.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2024-04-16
- WINDTREE THERAPEUTICS INC /DE/ severance costs for the quarter ending 2023-06-30 was $200.00K.
- WINDTREE THERAPEUTICS INC /DE/ severance costs for the quarter ending 2022-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ severance costs for the quarter ending 2022-09-30 was $100.00K.
- WINDTREE THERAPEUTICS INC /DE/ severance costs for the quarter ending 2022-06-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ severance costs for fiscal 2022 was $400.00K.
- WINDTREE THERAPEUTICS INC /DE/ severance costs for fiscal 2015 was $1.90M.
| Period end | Severance Costs 3 month | Severance Costs 3 month as first filed | Severance Costs 6 month | Severance Costs 6 month as first filed | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-07 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $100.00K derived: sum of 2 quarters · filed 2024-04-16 | $100.00K derived: sum of 3 quarters · filed 2024-04-16 | $400.00K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | $100.00K derived: sum of 2 quarters · filed 2023-08-07 | $400.00K 10-Q · filed 2023-08-07 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $300.00K 10-Q · filed 2023-08-07 | $400.00K 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-15 | $400.00K 10-Q · filed 2022-05-05 | ||||
| 2017-09-30 | $200.00K 10-K · filed 2018-04-17 | |||||
| 2015-12-31 | $1.90M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |